The world's first risk analysis combining genome and life habits

The impact of genes on non communicable diseases such as type 2 diabetes and coronary artery disease is significant. Conventional risk indicators do not accurately recognise the genetic risk of multifactorial diseases, although the genetic impact of these diseases is generally recognised.

In addition to the genetic risk assessment, it is essential to identify what are the most important lifestyle factors for You to support Your health. Enabling You to maintain Your health as long as possible, we bring the world's first risk analysis combining genome and lifestyle risk factors to help you.

Health is in Our DNA

More information about Negen gene tests

We have developed a risk calculator for You to see your risk projections and how Your lifestyle values alters the risk for coronary heart disease and type 2 diabetes. The counter combines three different genetic profiles in your lifestyle - low, average and high risk profiles. By ordering the Negen 360 genomic analysis, you will receive Your individual genomic risk factors presented in the calculator and many other features.

Try the Calculator

Consumer gene tests
Biobanks

Negen 360

Negen 360 is our most comprehensive analysis package. The analysis includes a genome wide test panel for coronary artery disease and type 2 diabetes combined with Your lifestyle values. It also includes a test for the most common mutations for deep vein thrombosis.

The test gives you a comprehensive assessment of the risks for the most common non communicable diseases and provides you tools to preserve Your health and maximize your healthy years.

Popular

Negen - Diabetes

In the Negen - Diabetes analysis, we examine the impact that your genome and lifestyles have on your risk of diabetes. The test includes an analysis of Type 2 diabetes as well as the conventional risk factors for Type 2 diabetes (predisposition to overweight, lipids and blood pressure).

Negen - Heart

In the Negen - Heart analysis, we examine the impact that your genome and lifestyles have on your risk of coronary heart disease. The test also includes an analysis of major risk factors: predisposition to overweight or obesity, lipids and blood pressure.

From sample collection to Data utilization

Donors rarely, if ever, receive any genetic information, even when their samples have been genotyped.

Cooperation between Negen and Biobanks enable the return of genetic health data in a cost-effective way, for the donor's benefit. The provision of health-related genetic information to donors in the biobanking industry concretely benefits both the donors and the biobanks.

Kimmo Aro

Managing Director
kimmo.aro@negen.fi
+358 40 149 3210

YOUR GENES, YOUR HABITS, YOUR HEALTH

Together, genes and lifestyle factors form a personal risk for contracting multifactorial diseases, which include diabetes and cardiovascular diseases. Analysing your personal genetic risk allows you to prevent the onset of these diseases as effectively as possible.

"Knowing my genetically increased risk for Coronary Heart Disease motivated me to lower my blood pressure by losing my weight 11 pounds and reducing the usage of salt.

Now my total risk is below the average in my age group”.

45 Year old male

News

Genomic testing provides the earliest indication of elevated disease risk

Early identification of disease risk enables effective prevention, which translates to more years of healthy living for the individual and significantly reduced healthcare costs.

Negen partners with National Institute for Health and Welfare (THL) on P5.fi study

THL and Negen to clarify usefulness of genetic risk assessment in personal health decisions

Genetic risk assessment delivers measurable value to consumers

Are currently available genomic testing services reliable? And can they deliver real value? Here we attempt to answer both questions comprehensively.